aubagio
sanofi winthrop industrie - teriflunomide - multippel sklerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
emla 25 mg/ g / 25 mg/ g
aspen pharma trading limited - lidokain / prilokain - krem - 25 mg/ g / 25 mg/ g
elocon 0.1 %
n.v. organon - kloosterstraat - mometasonfuroat - krem - 0.1 %
elocon 0.1 %
n.v. organon - kloosterstraat - mometasonfuroat - liniment, oppløsning - 0.1 %
elocon 0.1 %
n.v. organon - kloosterstraat - mometasonfuroat - salve - 0.1 %
pilexam 100 mg/ ml
pilum pharma a/s - traneksamsyre - injeksjonsvæske, oppløsning - 100 mg/ ml
emla 25 mg / 25 mg
aspen pharma trading limited - lidokain / prilokain - medisinert plaster - 25 mg / 25 mg
tapin 25 mg / 25 mg
orifarm generics a/s - lidokain / prilokain - medisinert plaster - 25 mg / 25 mg